• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

储存期间与吸附剂形成的氢键作用决定了药物从固体分散体颗粒中的溶出。

Hydrogen bonding with adsorbent during storage governs drug dissolution from solid-dispersion granules.

作者信息

Gupta Manish K, Tseng Yin-Chao, Goldman David, Bogner Robin H

机构信息

School of Pharmacy, University of Connecticut, Storrs 06269, USA.

出版信息

Pharm Res. 2002 Nov;19(11):1663-72. doi: 10.1023/a:1020905412654.

DOI:10.1023/a:1020905412654
PMID:12458672
Abstract

PURPOSE

To investigate changes in drug dissolution on storage of ternary solid-dispersion granules containing poorly water-soluble drugs.

METHODS

Hot-melt granulation was used to prepare ternary solid-dispersion granules in which the drug was dispersed in a carrier and coated onto an adsorbent. Seven drugs including four carboxylic acid-containing drugs (BAY 12-9566, naproxen, ketoprofen, and indomethacin). a hydroxyl-containing drug (testosterone), an amide-containing drug (phenacetin), and a drug with no proton-donating group (progesterone) were studied. Gelucire 50/13 and polyethylene glycol (PEG) 8000 were used as dispersion carriers whereas Neusilin US2 (magnesium aluminosilicate) was used as the surface adsorbent.

RESULTS

Two competing mechanisms have been proposed to explain the complex changes observed in drug dissolution upon storage of solid dispersion granules. Conversion of the crystalline drug to the amorphous hydrogen bonded (to Neusilin) state seems to increase dissolution, whereas, the phenomenon of Ostwald ripening can be used to explain the decrease in drug dissolution upon storage. The solubility of the drug in Gelucire is a crucial factor in determining the predominant mechanism by governing the flux toward the surface of Neusilin. The mobility for this phenomenon was provided by the existence of the eutectic mixture in the molten liquid state during storage.

CONCLUSIONS

A competitive balance between hydrogen bonding of the drugs with Neusilin and Ostwald ripening determines drug dissolution from solid-dispersion granules upon storage.

摘要

目的

研究含难溶性药物的三元固体分散体颗粒在储存过程中药物溶出度的变化。

方法

采用热熔制粒法制备三元固体分散体颗粒,其中药物分散于载体中并包被于吸附剂上。研究了七种药物,包括四种含羧酸药物(BAY 12 - 9566、萘普生、酮洛芬和吲哚美辛)、一种含羟基药物(睾酮)、一种含酰胺药物(非那西丁)以及一种无质子供体基团的药物(孕酮)。采用Gelucire 50/13和聚乙二醇(PEG)8000作为分散载体,而Neusilin US2(硅酸铝镁)用作表面吸附剂。

结果

提出了两种相互竞争的机制来解释固体分散体颗粒储存后药物溶出度观察到的复杂变化。结晶药物向无定形氢键结合(与Neusilin)状态的转变似乎会增加溶出度,而奥斯特瓦尔德熟化现象可用于解释储存后药物溶出度的降低。药物在Gelucire中的溶解度是通过控制向Neusilin表面的通量来决定主要机制的关键因素。储存期间熔融液态中共晶混合物的存在为这种现象提供了流动性。

结论

药物与Neusilin的氢键作用和奥斯特瓦尔德熟化之间的竞争平衡决定了储存后固体分散体颗粒中药物的溶出度。

相似文献

1
Hydrogen bonding with adsorbent during storage governs drug dissolution from solid-dispersion granules.储存期间与吸附剂形成的氢键作用决定了药物从固体分散体颗粒中的溶出。
Pharm Res. 2002 Nov;19(11):1663-72. doi: 10.1023/a:1020905412654.
2
Mechanism for further enhancement in drug dissolution from solid-dispersion granules upon storage.固体分散体颗粒在储存时药物溶出进一步增强的机制。
Pharm Dev Technol. 2002 Jan;7(1):103-12. doi: 10.1081/pdt-120002236.
3
Enhanced drug dissolution and bulk properties of solid dispersions granulated with a surface adsorbent.用表面吸附剂制粒的固体分散体的药物溶出度和整体性质增强。
Pharm Dev Technol. 2001 Nov;6(4):563-72. doi: 10.1081/pdt-120000294.
4
A One-Step Twin-Screw Melt Granulation with Gelucire 48/16 and Surface Adsorbent to Improve the Solubility of Poorly Soluble Drugs: Effect of Formulation Variables on Dissolution and Stability.一步法双螺杆熔融制粒联合 Gelucire 48/16 和表面吸附剂改善难溶性药物的溶解度:制剂变量对溶出度和稳定性的影响。
AAPS PharmSciTech. 2021 Feb 19;22(3):79. doi: 10.1208/s12249-021-01945-8.
5
Melt dispersion granules: formulation and evaluation to improve oral delivery of poorly soluble drugs - a case study with valsartan.熔融分散颗粒:改善难溶性药物口服给药的制剂与评价——以缬沙坦为例
Drug Dev Ind Pharm. 2015 Jun;41(6):888-97. doi: 10.3109/03639045.2014.911308. Epub 2014 May 5.
6
Formation of physically stable amorphous drugs by milling with Neusilin.通过与Neusilin研磨形成物理稳定的无定形药物。
J Pharm Sci. 2003 Mar;92(3):536-51. doi: 10.1002/jps.10308.
7
Enhanced Dissolution of a Porous Carrier-Containing Ternary Amorphous Solid Dispersion System Prepared by a Hot Melt Method.热熔法制备含多孔载体的三元无定形固体分散体系统的增强溶解。
J Pharm Sci. 2018 Jan;107(1):362-371. doi: 10.1016/j.xphs.2017.09.025. Epub 2017 Oct 6.
8
Design, optimization, preparation and evaluation of dispersion granules of valsartan and formulation into tablets.缬沙坦分散片剂的设计、优化、制备及评价与片剂剂型研究
Curr Drug Deliv. 2009 Jan;6(1):28-37. doi: 10.2174/156720109787048258.
9
Physicochemical characterisation, drug polymer dissolution and in vitro evaluation of phenacetin and phenylbutazone solid dispersions with polyethylene glycol 8000.非那西丁和保泰松与聚乙二醇8000的固体分散体的物理化学表征、药物聚合物溶解及体外评价
J Pharm Sci. 2011 Oct;100(10):4281-94. doi: 10.1002/jps.22613. Epub 2011 May 10.
10
Formulation performance and processability window for manufacturing a dual-polymer amorphous solid dispersion via hot-melt extrusion and strand pelletization.通过热熔挤出和条粒化制备双聚合物无定形固体分散体的配方性能和可加工窗口。
Int J Pharm. 2018 Dec 20;553(1-2):408-421. doi: 10.1016/j.ijpharm.2018.10.035. Epub 2018 Oct 14.

引用本文的文献

1
Investigation of hot melt extrusion process parameters on solubility and tabletability of atorvastatin calcium in presence of Neusilin US2.在存在Neusilin US2的情况下,研究热熔挤出工艺参数对阿托伐他汀钙溶解度和可压性的影响。
J Drug Deliv Sci Technol. 2023 Jan;79. doi: 10.1016/j.jddst.2022.104075. Epub 2022 Dec 13.
2
Enhanced Solubility and Biological Activity of Dexibuprofen-Loaded Silica-Based Ternary Solid Dispersions.载有右布洛芬的二氧化硅基三元固体分散体的溶解度和生物活性增强
Pharmaceutics. 2023 Jan 24;15(2):399. doi: 10.3390/pharmaceutics15020399.
3
Amalgamation of Solid Dispersion and Melt Adsorption Technique: Improved In Vitro and In Vivo Performance of Ticagrelor Tablets.

本文引用的文献

1
Mechanism for further enhancement in drug dissolution from solid-dispersion granules upon storage.固体分散体颗粒在储存时药物溶出进一步增强的机制。
Pharm Dev Technol. 2002 Jan;7(1):103-12. doi: 10.1081/pdt-120002236.
2
Enhanced drug dissolution and bulk properties of solid dispersions granulated with a surface adsorbent.用表面吸附剂制粒的固体分散体的药物溶出度和整体性质增强。
Pharm Dev Technol. 2001 Nov;6(4):563-72. doi: 10.1081/pdt-120000294.
3
Stability of amorphous indomethacin compounded with silica.与二氧化硅复合的无定形吲哚美辛的稳定性
固体分散体和熔融吸附技术的联合应用:替格瑞洛片剂的体外和体内性能的改善。
AAPS PharmSciTech. 2021 Oct 21;22(8):257. doi: 10.1208/s12249-021-02138-z.
4
Pharmaceutical amorphous solid dispersion: A review of manufacturing strategies.药物非晶态固体分散体:制备策略综述
Acta Pharm Sin B. 2021 Aug;11(8):2505-2536. doi: 10.1016/j.apsb.2021.05.014. Epub 2021 Jun 5.
5
Stress-Dependent Particle Interactions of Magnesium Aluminometasilicates as Their Performance Factor in Powder Flow and Compaction Applications.镁铝硅酸盐的应力相关颗粒相互作用作为其在粉末流动和压实应用中的性能因素
Materials (Basel). 2021 Feb 14;14(4):900. doi: 10.3390/ma14040900.
6
Development of ternary solid dispersions with hydrophilic polymer and surface adsorbent for improving dissolution rate of carbamazepine.用于提高卡马西平溶出速率的含亲水性聚合物和表面吸附剂的三元固体分散体的研制。
Saudi Pharm J. 2018 Jul;26(5):725-732. doi: 10.1016/j.jsps.2018.02.017. Epub 2018 Feb 7.
7
Chemico-calorimetric analysis of amorphous granules manufactured via continuous granulation process.通过连续造粒工艺制造的无定形颗粒的化学-量热分析。
Drug Deliv Transl Res. 2018 Dec;8(6):1658-1669. doi: 10.1007/s13346-018-0519-3.
8
Preparation and Characterization of All-Biomass Soy Protein Isolate-Based Films Enhanced by Epoxy Castor Oil Acid Sodium and Hydroxypropyl Cellulose.环氧蓖麻油酸钠和羟丙基纤维素增强的全生物质大豆分离蛋白基薄膜的制备与表征
Materials (Basel). 2016 Mar 15;9(3):193. doi: 10.3390/ma9030193.
9
Inclusion of Digestible Surfactants in Solid SMEDDS Formulation Removes Lag Time and Influences the Formation of Structured Particles During Digestion.在固体自微乳化药物传递系统(SMEDDS)制剂中加入可消化表面活性剂可消除滞后时间,并影响消化过程中结构化颗粒的形成。
AAPS J. 2017 May;19(3):754-764. doi: 10.1208/s12248-016-0036-6. Epub 2017 Jan 23.
10
Development of Solid SEDDS, IV: Effect of Adsorbed Lipid and Surfactant on Tableting Properties and Surface Structures of Different Silicates.固体自乳化药物递送系统的开发,IV:吸附的脂质和表面活性剂对不同硅酸盐压片性能和表面结构的影响
Pharm Res. 2013 Jun 26;30(12):3170-85. doi: 10.1007/s11095-013-1114-4.
Int J Pharm. 2001 Sep 11;226(1-2):81-91. doi: 10.1016/s0378-5173(01)00776-1.
4
Annealing to optimize the primary drying rate, reduce freezing-induced drying rate heterogeneity, and determine T(g)' in pharmaceutical lyophilization.退火以优化一次干燥速率,降低冷冻诱导的干燥速率不均匀性,并确定药物冻干中的玻璃化转变温度(T(g)')。
J Pharm Sci. 2001 Jul;90(7):872-87. doi: 10.1002/jps.1040.
5
Improving drug solubility for oral delivery using solid dispersions.使用固体分散体提高口服给药的药物溶解度。
Eur J Pharm Biopharm. 2000 Jul;50(1):47-60. doi: 10.1016/s0939-6411(00)00076-x.
6
Physical properties of solid molecular dispersions of indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyl-acetate) in relation to indomethacin crystallization.吲哚美辛与聚(乙烯基吡咯烷酮)和聚(乙烯基吡咯烷酮 - 共 - 乙酸乙烯酯)的固体分子分散体的物理性质与吲哚美辛结晶的关系
Pharm Res. 1999 Nov;16(11):1722-8. doi: 10.1023/a:1018906132279.
7
Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs.难溶性药物的固体分散体:早期的前景、后续的问题及近期的突破
J Pharm Sci. 1999 Oct;88(10):1058-66. doi: 10.1021/js980403l.
8
Solid-state characteristics of amorphous sodium indomethacin relative to its free acid.非晶态吲哚美辛钠相对于其游离酸的固态特性。
Pharm Res. 1999 Aug;16(8):1186-92. doi: 10.1023/a:1018985110956.
9
Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions.聚维酮与吲哚美辛在无定形分子分散体中相互作用的光谱表征
Pharm Res. 1997 Dec;14(12):1691-8. doi: 10.1023/a:1012167410376.
10
Pharmaceutical applications of solid dispersion systems.固体分散体系统的药物应用。
J Pharm Sci. 1971 Sep;60(9):1281-302. doi: 10.1002/jps.2600600902.